Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study.

Autor: England JT; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada. james.england@mail.utoronto.ca.; Division of Medical Oncology & Malignant Hematology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. james.england@mail.utoronto.ca., Szuber N; Maisonneuve-Rosemont Hospital, University of Montreal, Quebec, QC, Canada., Sirhan S; Jewish General Hospital, McGill University, Montreal, QC, Canada., Dunne T; Division of Hematology, Newfoundland and Labrador Health Services, St. John's, NL, Canada., Cerquozzi S; Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada., Hill M; The Ottawa Hospital Research Institute, Ottawa, Ottawa, ON, Canada., Villeneuve PJA; The Ottawa Hospital Research Institute, Ottawa, Ottawa, ON, Canada.; The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada., Ho JM; Division of Hematology, Department of Medicine, Western University, London Health Sciences Centre, London, ON, Canada., Sadikovic B; Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON, Canada., Bhai P; Department of Pathology and Laboratory Medicine, London Health Sciences Centre, London, ON, Canada., Krishnan N; Royal Victoria Regional Health Center, Barrie, ON, Canada., Dowhanik S; Department of Oncology, McMaster University, Hamilton, ON, Canada., Hillis C; Department of Oncology, McMaster University, Hamilton, ON, Canada., Capo-Chichi JM; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, ON, Canada., Tsui H; Department of Hematopathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Cheung V; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Gauthier K; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Sibai H; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Davidson MB; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Bankar A; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Kotchetkov R; Royal Victoria Regional Health Center, Barrie, ON, Canada., Gupta V; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Maze D; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

Publikováno v: Leukemia [Leukemia] 2024 Mar; Vol. 38 (3), pp. 570-578. Date of Electronic Publication: 2024 Feb 06.

Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia.

Autor: Fulcher J; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada., Berardi P; Department of Pathology and Laboratory Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada., Christou G; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada., Villeneuve PJA; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada., Bredeson C, Sabloff M; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, Canada.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2021 Sep; Vol. 62 (9), pp. 2295-2297. Date of Electronic Publication: 2021 Mar 21.